196 related articles for article (PubMed ID: 36369196)
1. Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII - an update.
Segna D; Mendoza YP; Lange NF; Rodrigues SG; Berzigotti A
Dig Liver Dis; 2023 Mar; 55(3):326-335. PubMed ID: 36369196
[TBL] [Abstract][Full Text] [Related]
2. Evolving portal hypertension through Baveno VII recommendations.
Mendizabal M; Cançado GGL; Albillos A
Ann Hepatol; 2024; 29(1):101180. PubMed ID: 37984701
[TBL] [Abstract][Full Text] [Related]
3. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B
J Hepatol; 2024 Mar; ():. PubMed ID: 38479612
[TBL] [Abstract][Full Text] [Related]
4. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
[TBL] [Abstract][Full Text] [Related]
5. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Balcar L; Semmler G; Stättermayer AF; Pinter M; Quehenberger P; Trauner M; Reiberger T; Mandorfer M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1854-1863.e10. PubMed ID: 36244661
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
7. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review.
Celsa C; Veneziano M; Di Giorgio FM; Cannova S; Lombardo A; Errigo E; Landro G; Simone F; Sinagra E; Calvaruso V
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792873
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnosis and follow-up of portal hypertension.
Thabut D; Weil D; Bouzbib C; Rudler M; Cassinotto C; Castéra L; Serste T; Oberti F; Ganne-Carrié N; de Lédinghen V; Bourlière M; Bureau C
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101767. PubMed ID: 34332128
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
[TBL] [Abstract][Full Text] [Related]
11. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
12. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography.
He R; Liu C; Grgurevic I; Guo Y; Xu H; Liu J; Liu Y; Wang X; Shi H; Madir A; Podrug K; Zhu Y; Hua Y; Wang K; Wen J; Su M; Zhang Q; Li J; Qi X
Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK
Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria.
Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK
Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932
[TBL] [Abstract][Full Text] [Related]
15. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease.
Odriozola A; Puente Á; Cuadrado A; Iruzubieta P; Arias-Loste MT; Redondo C; Rivas C; Fábrega E; Crespo J; Fortea JI
Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787
[TBL] [Abstract][Full Text] [Related]
16. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
Paternostro R; Reiberger T; Bucsics T
World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
[TBL] [Abstract][Full Text] [Related]
17. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
[TBL] [Abstract][Full Text] [Related]
18. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study.
Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X
Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis.
Dajti E; Ravaioli F; Zykus R; Rautou PE; Elkrief L; Grgurevic I; Stefanescu H; Hirooka M; Fraquelli M; Rosselli M; Chang PEJ; Piscaglia F; Reiberger T; Llop E; Mueller S; Marasco G; Berzigotti A; Colli A; Festi D; Colecchia A;
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):816-828. PubMed ID: 37478880
[TBL] [Abstract][Full Text] [Related]
20. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A
Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
